BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1293 related articles for article (PubMed ID: 18180524)

  • 41. The use of antithrombotics for acute coronary syndromes in the emergency department: considerations and impact.
    Mukherjee D; Eagle KA
    Prog Cardiovasc Dis; 2007; 50(3):167-80. PubMed ID: 17976502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.
    Kandzari DE; Roe MT; Chen AY; Lytle BL; Pollack CV; Harrington RA; Ohman EM; Gibler WB; Peterson ED
    Am Heart J; 2005 Mar; 149(3):474-81. PubMed ID: 15864236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An analysis of the Association of Society of Chest Pain Centers Accreditation to American College of Cardiology/American Heart Association non-ST-segment elevation myocardial infarction guideline adherence.
    Chandra A; Glickman SW; Ou FS; Peacock WF; McCord JK; Cairns CB; Peterson ED; Ohman EM; Gibler WB; Roe MT
    Ann Emerg Med; 2009 Jul; 54(1):17-25. PubMed ID: 19282062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Harrington RA; Becker RC; Cannon CP; Gutterman D; Lincoff AM; Popma JJ; Steg G; Guyatt GH; Goodman SG
    Chest; 2008 Jun; 133(6 Suppl):670S-707S. PubMed ID: 18574276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle].
    Savonitto S; Klugmann S
    Ital Heart J Suppl; 2004 Mar; 5(3):167-76. PubMed ID: 15116860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimal timing of intervention in non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Registry.
    Ryan JW; Peterson ED; Chen AY; Roe MT; Ohman EM; Cannon CP; Berger PB; Saucedo JF; DeLong ER; Normand SL; Pollack CV; Cohen DJ;
    Circulation; 2005 Nov; 112(20):3049-57. PubMed ID: 16275863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Mehta RH; Li Y; Brindis RG; Smith SC; Rumsfeld JS; Gibler WB; Ohman EM; Peterson ED
    Circulation; 2007 Sep; 116(10):1153-61. PubMed ID: 17709638
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.
    Fitchett D; Goodman SG; Gupta M; Langer A
    Can J Cardiol; 2002 Nov; 18(11):1179-90. PubMed ID: 12464982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.
    Spinler SA
    Am J Manag Care; 2009 Mar; 15(2 Suppl):S42-7. PubMed ID: 19355808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians.
    Pollack CV; Gibler WB
    Ann Emerg Med; 2001 Sep; 38(3):229-40. PubMed ID: 11524641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes.
    Yan AT; Yan RT; Tan M; Fung A; Cohen EA; Fitchett DH; Langer A; Goodman SG;
    Arch Intern Med; 2007 May; 167(10):1009-16. PubMed ID: 17533203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Local hospital networks for STEMI treatment for a population of half a million inhabitants increase the use of invasive treatment of acute coronary syndromes to the European recommended level. The Małopolska Registry of Acute Coronary Syndromes 2005-2006.
    Dudek D; Siudak Z; Dziewierz A; Rakowski T; Mielecki W; Brzeziński M; Zasada W; Bartuś S; Januś B; Dubiel JS
    Kardiol Pol; 2008 May; 66(5):489-97, discussion 498-9. PubMed ID: 18537056
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [How to administer antithrombotic therapy in non-ST-elevation acute coronary syndromes: guidelines and clinical practice].
    Mafrici A
    Ital Heart J; 2005 May; 6 Suppl 3():24S-27S. PubMed ID: 15945316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical benefits of adjunctive tirofiban therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Shen J; Zhang Q; Zhang RY; Zhang JS; Hu J; Yang ZK; Zheng AF; Zhang X; Shen WF
    Coron Artery Dis; 2008 Jun; 19(4):271-7. PubMed ID: 18480672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors and impact of bleeding complications in percutaneous coronary intervention, acute coronary syndromes, and ST-segment elevation myocardial infarction.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):9C-15C. PubMed ID: 19695355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unstable angina and non-ST-segment myocardial infarction: an evidence-based approach to management.
    Kou V; Nassisi D
    Mt Sinai J Med; 2006 Jan; 73(1):449-68. PubMed ID: 16470325
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Avoiding intelligence failures in the cardiac catheterization laboratory: Strategies for the safe and rational use of dalteparin or enoxaparin during percutaneous coronary intervention.
    Marmur JD; Bullock-Palmer RP; Poludasu S; Cavusoglu E
    J Invasive Cardiol; 2009 Dec; 21(12):653-64. PubMed ID: 19966370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glycoprotein IIb-IIIa inhibitors in the emergency department for patients with non-ST-elevation acute coronary syndromes: principles and practices.
    Lefebvre CW; Hoekstra JW; Bonaca M; Giugliano R
    J Emerg Med; 2009 Feb; 36(2):162-70. PubMed ID: 18353601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.